Subscribe:

Oct 31, 2017

10/31/2017: Is the estate tax saving America from aristocracy?

The tax prevents individuals worth $5.5 million or more from passing on their estate untaxed, and Republicans have sworn it will be the first thing to go when tax reform comes. Plus, the story behind the lethal toxin that became Botox, and the company guarding it. And Kai Ryssdal interviews activist investor Bill Ackman, who is vying for control over payroll processing company ADP.

10/31/2017: Is the estate tax saving America from aristocracy? — Leon Neal/AFP/Getty Images

Subscribe:

Segments From This Episode

Botox is a multi-billion dollar, potentially deadly monopoly
by Kai Ryssdal, Emily Henderson and Sean McHenry
Andreas Rentz/Getty Images
The product comes from a substance so lethal that it could be used as a potential agent of bioterrorism.
Why Bill Ackman sees activist investing as a moral crusade
by Kai Ryssdal, Bridget Bodnar and Sean McHenry
Matthew Eisman/Getty Images for Hamptons International Film Festival
For the Pershing Square Capital Management CEO, activist investing is just as much a moral calling as it is a lucrative one
Killing the "death tax": Is it fair?
Alex Wong/Getty Images
Depends on who you ask.

Music from the episode

The tax prevents individuals worth $5.5 million or more from passing on their estate untaxed, and Republicans have sworn it will be the first thing to go when tax reform comes. Plus, the story behind the lethal toxin that became Botox, and the company guarding it. And Kai Ryssdal interviews activist investor Bill Ackman, who is vying for control over payroll processing company ADP.